» Articles » PMID: 32512805

Growing Trend of Fighting Infections in Aquaculture Environment-Opportunities and Challenges of Phage Therapy

Overview
Specialty Pharmacology
Date 2020 Jun 10
PMID 32512805
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Phage therapy, a promising alternative to antimicrobial treatment of bacterial diseases, is getting more and more popular, especially due to the rising awareness of antibiotic resistance and restrictions in antibiotics' use. During recent years, we observed a growing trend of bacteriophages' application in aquaculture, which in each year reports high losses due to bacterial diseases. This review provides an update of the status of bacteriophage therapy for the treatment and prevention of infections in the aquatic environment. As it is still mostly in the scientific stage, there are a few constraints that may prevent effective therapy. Therefore, specific characteristics of bacteriophages, that can act in favor or against their successful use in treatment, were described. We underlined aspects that need to be considered: specificity of phages, bacterial resistance, safety, immune response of the host organism, formulation, administration and stability of phage preparations as well as bacteriophages' influence on the environment. The biggest challenge to overcome is finding the right balance between the desired and problematic characteristics of bacteriophages. Finally, regulatory approval challenges may be encountered by bacteriophage manufacturers. Even though there are still some technical constraints connected with the global use of bacteriophage therapy, it was concluded that it can be successfully applied in aquaculture.

Citing Articles

Two virulent Vibrio campbellii phages with potential for phage therapy in aquaculture.

Ding H, Shi K, Hsiao M, Li W, Liu X, Xu J BMC Microbiol. 2025; 25(1):99.

PMID: 40021993 PMC: 11869677. DOI: 10.1186/s12866-025-03803-0.


The Potential of Phage Treatment to Inactivate Planktonic and Biofilm-Forming .

Martinho I, Braz M, Duarte J, Bras A, Oliveira V, Gomes N Microorganisms. 2024; 12(9).

PMID: 39338470 PMC: 11433742. DOI: 10.3390/microorganisms12091795.


Current status of clinical trials for phage therapy.

Uchechukwu C, Shonekan A J Med Microbiol. 2024; 73(9).

PMID: 39320361 PMC: 11423923. DOI: 10.1099/jmm.0.001895.


Effect of Phage Spray on Hatchability and Chick Quality of Eggs Contaminated with Typhimurium.

Wang L, Dong Q, Tang K, Han K, Bai H, Yin Y Viruses. 2024; 16(8).

PMID: 39205312 PMC: 11359902. DOI: 10.3390/v16081338.


Partial Characterization of Three Bacteriophages Isolated from Aquaculture Hatchery Water and Their Potential in the Biocontrol of spp.

Yasa I, Evran S, Eren Eroglu A, Onder C, Allahyari M, Menderes G Microorganisms. 2024; 12(5).

PMID: 38792725 PMC: 11123731. DOI: 10.3390/microorganisms12050895.


References
1.
Cooper I . A review of current methods using bacteriophages in live animals, food and animal products intended for human consumption. J Microbiol Methods. 2016; 130:38-47. DOI: 10.1016/j.mimet.2016.07.027. View

2.
Merril C, Biswas B, Carlton R, Jensen N, Creed G, Zullo S . Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A. 1996; 93(8):3188-92. PMC: 39580. DOI: 10.1073/pnas.93.8.3188. View

3.
Cairns J, Coloma S, Sivonen K, Hiltunen T . Evolving interactions between diazotrophic cyanobacterium and phage mediate nitrogen release and host competitive ability. R Soc Open Sci. 2017; 3(12):160839. PMC: 5210698. DOI: 10.1098/rsos.160839. View

4.
Assefa A, Abunna F . Maintenance of Fish Health in Aquaculture: Review of Epidemiological Approaches for Prevention and Control of Infectious Disease of Fish. Vet Med Int. 2018; 2018:5432497. PMC: 5846361. DOI: 10.1155/2018/5432497. View

5.
Loc Carrillo C, Atterbury R, El-Shibiny A, Connerton P, Dillon E, Scott A . Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol. 2005; 71(11):6554-63. PMC: 1287621. DOI: 10.1128/AEM.71.11.6554-6563.2005. View